The accumulation of CAR-T cells in tumor tissues can be promoted by the overexpression of CCRs from T cells (e.g., CCR2b and C-C motif chemokine receptor 4) or by the overexpression of chemokines from tumor cells (e.g., RANTES and IL-15) [136]. This evidence concerns the gene CCL5 and neoplasm.